Quantro and Boehringer Ingelheim collaborate on inhibitors
Deal represents part of Boehringer Ingelheim’s strategy to provide breakthrough cancer therapies
Read More
Tag: Quantro
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
